Journals / Turkish Journal of Gastroenterology / 2018 / Cilt: 29 - Sayı: 2

Prevalence of the integration status for human papillomavirus 16 in esophageal carcinoma samples

Pages
157–163
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results indicate that integration of HPV16 was more common in the host genome than in the episome genome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: To investigate the etiology of esophageal cancer (EC) related with human papillomavirus (HPV) infection.Materials and Methods: Fresh surgically resected tissue samples and clinical information were obtained from 189 patients.
📊
Key Findings & Data:Genomic DNA was extracted, and HPV was detected using polymerase chain reaction (PCR) with HPV L1 gene primers of MY09/11; HPV16 was de-tected using HPV16 E6 type-specific primer sets.
💡
Conclusion & Impact:The results indicate that integration of HPV16 was more common in the host genome than in the episome genome.
🔬Design:Research Article
📍Scope:189 samples
⚙️Variables:Domain Parameters

Özet

Background/Aims: To investigate the etiology of esophageal cancer (EC) related with human papillomavirus (HPV) infection.Materials and Methods: Fresh surgically resected tissue samples and clinical information were obtained from 189 patients. Genomic DNA was extracted, and HPV was detected using polymerase chain reaction (PCR) with HPV L1 gene primers of MY09/11; HPV16 was de-tected using HPV16 E6 type-specific primer sets. Copies of HPV16 E2, E6, and the human housekeeping gene β-actin were tested using quantitative PCR to analyze the relationship between HPV16 integration and esophageal squamous cell carcinoma and the relationship between the HPV16 integration status and clinical information of patients.Results: Of the 189 samples, 168 HPV-positive samples were detected, of which 76 were HPV16 positive. Among the HPV16 positive samples, 2 cases (E2/E6 ratio>1) were 2.6% (2/76) purely episomal, 65 (E2/E6 ratio between 0 and 1) were 85.6% (65/76) mixture of integrated and episomal, and 9 (E2/E6 ratio=0) were 11.8% (9/76) purely integrated. The results indicate that integration of HPV16 was more common in the host genome than in the episome genome. The prevalence rate of HPV16 integration is increasing with the patho-logical stage progression of esophageal carcinoma (EC).Conclusion: A high prevalence of HPV16 suggested that HPV16 has an etiological effect on the progress of EC. Integration of HPV16 is more common than episome genome in the host cells, indicating that continuous HPV infection is the key to esophageal epithelial cell malignant conversion and canceration.

🔖

Cite This Article

LI, S., SHEN, H., LI, J., HOU, X., ZHANG, K., LI, J. (2018). Prevalence of the integration status for human papillomavirus 16 in esophageal carcinoma samples. Turkish Journal of Gastroenterology, Cilt: 29 - Sayı: 2, 157–163. https://ajindex.com/articles/410076

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Constandinou-Williams C, Collins SI, Roberts S, et al. Is human pap-illomavirus viral load a clinically useful predictive marker: a longitudinal study. Cancer Epidemiol Biomarkers Prev 2010
  2. [CrossRef] 32. Theelen W, Reijans M, Simons G, et al. A new multiparameter as-say to assess HPV 16/18, viral load and physical status together with gain of telomerase genes in HPV-related cancers. Int J Cancer 2010
  3. Si HX, Tsao SW, Poon CS, et al. Physical status of HPV16 in esophageal squamous cell carcinoma, J Clin Virol 2005
  4. [CrossRef] 30. Badaracco G, Venuti A, Sedati A. et al. HPV16 and HPV18 in genital tumors: significantly different levels of viral integration and correla-tion to tumor invasiveness. J Med Virol 2002
  5. [CrossRef] 29. Hugo AP, Peyton CL, Joste NE, et al. Human papillomavirus type 16 integration in cervical carcinoma in situ and invasive cervical cancer. J Clin Microbiol 2006
  6. [CrossRef] 28. Liang H, Fan JH, Qiao YL. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med 2017
  7. [CrossRef] 27. Jain S, Dhingra S. Pathology of esophageal cancer and Barrett’s esophagus. Ann Cardiothorac Surg 2017
  8. [CrossRef] 26. Castro C, Peleteiro B, Lunet N. Modifiable factors and esopha-geal cancer: a systematic review of published meta-analyses. J Gas-troenterol 2018
  9. [CrossRef] 25. Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol 2008
  10. [CrossRef] 24. Han-Ze Zhang, Guang-Fu Jin, and Hong-Bing Shen. Epidemio-logic differences in esophageal cancer between Asian and Western populations. Chin J Cancer 2012
  11. [CrossRef] 23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001
  12. [CrossRef] 22. Kim ST, Chun JW, Park G, et al. Comparative quantification of plasma TDRD7 mRNA in cataract patients by real-time polymerase chain reaction. Korean J Ophthalmol 2014
  13. [CrossRef] 21. Karlsen F, Kalantari M, Jenkins A, et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 1996
  14. Si HX, Tsao SW, Poon CS, et al. Viral load of HPV in esophageal squa-mous cell carcinoma. Int J Cancer 2003
  15. [CrossRef] 19. Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncopro-tein encoded by human